Home › Atrial Fibrillation › Idaho › Boise
Atrial Fibrillation clinical trials in Boise, ID
3 studies for Atrial Fibrillation are looking for participants at sites in and around Boise (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3
RecruitingPhase 3
- St Luke's Regional Medical Center, Ltd, Boise
The Fourth Left Atrial Appendage Occlusion Study
Recruiting
- St Luke's Regional Medical Center, Ltd, Boise
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
RecruitingPhase 3
- Saint Alphonsus Regional Medical Center - Boise, Boise
About Atrial Fibrillation
Atrial fibrillation (AF or AFib) is the most common type of arrhythmia (irregular heartbeat). Read about symptoms and treatment.
More about Atrial Fibrillation on MedlinePlus
Atrial Fibrillation trials in other cities
- Boston, MA19 studies
- New York City, NY19 studies
- Atlanta, GA17 studies
- Cleveland, OH17 studies
- Jonesboro, AR13 studies
- Pittsburgh, PA12 studies
- Philadelphia, PA12 studies
- Ann Arbor, MI12 studies
- Chicago, IL12 studies
- Orlando, FL11 studies
- Cincinnati, OH10 studies
- Austin, TX10 studies
Other studies in Boise
- Non-Small Cell Lung Cancer14 studies
- Lung Cancer11 studies
- Prostate Cancer9 studies
- Acute Myeloid Leukemia8 studies
- Colon Cancer7 studies
- Breast Cancer7 studies
- Colorectal Cancer7 studies
- Respiratory Distress Syndrome6 studies
- Melanoma6 studies
- Burkitt Lymphoma5 studies
- Myelodysplastic Syndromes5 studies
- Ovarian Cancer4 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.